Unilever is buying the health drinks business of GSK in India, Bangladesh and 20 other mainly Asian countries.
It includes drinks under the Horlicks brand.
Unilever is paying €3.3bn for the business.
“Horlicks has made a significant contribution to GSK and to the health of consumers across India for many decades and we believe Unilever is well placed to maximise its future potential," said Emma Walmsley, chief executive of GSK.
"Proceeds from this transaction will be used to support the Group’s strategic priorities, including investing in our pharmaceutical business.”
An interesting fact about Horlicks marketing - while here it's sold as a bedtime drink, in India it's sold as a energy one. Read about it here.